Memory Pharmaceuticals Corp
SEC CIK 1062216 · MEMY · last insider filing 2009-01-08
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Evnin Anthony B | Director | filed 2006 - 2009 |
| Kailian Vaughn M | Director · President and CEO | filed 2006 - 2009 |
| Kriebel Robert I | Director | filed 2006 - 2009 |
| Blake Paul | Director | filed 2007 - 2009 |
| Sulat James R | Director · President & CEO | filed 2006 - 2009 |
| Gilbert Walter PHD | Director | filed 2006 - 2009 |
| Fleming Jonathan | Director | filed 2006 - 2009 |
| Meyers Michael E | Director | filed 2006 - 2009 |
| Young Peter | Director | filed 2006 - 2009 |
| Lowe David A | Director · Chief Scientific Officer | filed 2006 - 2009 |
| Scullion Tony | Director · President & CEO | filed 2006 - 2006 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Lalani Jzaneen | VP Legal Affairs | filed 2006 - 2009 |
| Smith Michael P | VP, Business Development | filed 2006 - 2009 |
| Murray Stephen R | VP Clinical Development | filed 2006 - 2009 |
| Donabauer Joseph M | Vice President & Controller | filed 2006 - 2007 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.